Q32 Bio Inc. (QTTB) Cash from Operations (2017 - 2026)

Q32 Bio has reported Cash from Operations for 10 years, with the latest figure at -$3.1 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 71.13% year-over-year to -$3.1 million in Q2 2026; TTM through Jun 2026 was -$19.8 million, a 63.34% increase from a year earlier, with the FY2025 full-year figure at -$33.5 million, up 50.46% from the prior year.
• Cash from Operations was -$3.1 million for Q2 2026 at Q32 Bio, up from -$6.3 million in the prior quarter.
• The five-year high for Cash from Operations was $15.9 million in Q3 2023, with the low at -$30.8 million in Q2 2022.
• Average Cash from Operations over 5 years is -$13.5 million, with a median of -$12.0 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 163.78% in 2023, then plunged 222.77% in 2024.
• Over 5 years, Cash from Operations stood at -$27.2 million in 2022, then surged by 60.61% to -$10.7 million in 2023, then fell by 6.65% to -$11.4 million in 2024, then soared by 45.92% to -$6.2 million in 2025, then surged by 50.24% to -$3.1 million in 2026.
• The last three Cash from Operations figures came in at -$3.1 million (Q2 2026), -$6.3 million (Q1 2026), and -$6.2 million (Q4 2025), per Business Quant data.